Recently, AIM announced a comprehensive deployment to integrate the DeepSeek large model, particularly in vaccine development, utilizing DeepSeek in conjunction with generative models and deep ...

HER2-positive breast cancer, once associated with poor outcomes, now sees improved prognosis due to targeted therapies like Herceptin. Combination therapies and neoadjuvant treatments have enhanced ...

Geyer and his colleagues found that among patients with HER2-positive early breast cancer, at a median follow-up of 8.4 years Kadcyla (ado-trastuzumab emtansine) showed sustained improvement in ...

The phase 3 study assessed vepdegestrant against AstraZeneca’s hormone med Faslodex in 624 patients with ER+/HER2- advanced or metastatic breast cancer who had already tried CDK 4/6 inhibitors ...

Credit: Shutterstock / Maria Sbytova. Pharma giant Pfizer and Arvinas’s human epidermal growth factor receptor 2 (HER2) negative breast cancer therapy, vepdegestrant, has seen mixed results after it ...

For the HEK293 F expression of RBD-SBD, it was cloned into pCDNA 3.1(+) between T7 and His-tag sequences. The construct contained the IL-2 signal peptide (AAB86861.1) for protein secretion. The final ...